Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentinUlrike Harre, Georg Schett, Roland Axmann et al.|Journal of Clinical Investigation|2012Cited by 708
Defining conditions where long-term glucocorticoid treatment has an acceptably low level of harm to facilitate implementation of existing recommendations: viewpoints from an EULAR task forceCindy Strehl, Frank Buttgereit, J. W. J. Bijlsma et al.|Annals of the Rheumatic Diseases|2016Cited by 331